Neuritic plaques are a key feature of Alzheimer's disease and normal aging.
Neuritic plaque within the hippocampal formation have a very characteristic
distribution in the molecular layer of the fascia dentata, where they are
aligned parallel to the granule cell layer. This precise predictable
pattern provides a unique opportunity to define plaque localization in
terms of both the distribution of afferents to the molecular layer and the
morphology of granule cell dendrites. Two sets of experiments will test
the hypothesis that changes in the distribution of afferents and change in
the morphology of granule cells develop as the first plaques appear. The
third set of experiment will examine the role of microglia and amyloid in
plaque formation in this well-defined population of neuritic plaques. The
ultimate goal of these experiments is to develop the molecular layer of the
fascia dentata as a model system in which to examine the pathogenesis of
neuritic plaques in Alzheimer's disease.
First, the distribution of afferents to the molecular layer in control and
Alzheimer's disease patients will be related to the laminar distribution of
neuritic plaques. Multiple anatomic marker will be used in each Rapid
Autopsy case. The perforant path from the entorhinal cortex will be
labeled with the fluorescent dye Dil. The cholinergic afferents from the
basal forebrain cholinergic nuclei will be labeled with
acetylcholinesterase histochemistry. Somatostatin and cholecystokinin
afferents will be labeled immunohistochemically. Second, the relationships
between the neuritin plaques and the granule cells will be defined.
Intracellular injections of Lucifer yellow will fill the dendritic trees so
that dendritic branching patterns and dendritic pathology can be correlated
with plaque location. The distribution of abnormal granule cell bodies
containing neurofibrillary tangles Pick-like bodies, or abnormal
neurofilament antigens will be correlated with the distribution of plaques
in the overlying molecular layer. Third, patterns of accumulation of
microglia and amyloid will be related to the above changes in the neuropil,
using RCA-1 lectin histochemistry to label microglia and Congo red staining
and amyloid beta protein immunohistochemistry to label amyloid. Amyloid
deposition will also be correlated with the age of onset of dementia,
duration of dementia and family history of dementia.
No Sub Projects information available for 1R01AG009216-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01AG009216-01
Patents
No Patents information available for 1R01AG009216-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01AG009216-01
Clinical Studies
No Clinical Studies information available for 1R01AG009216-01
News and More
Related News Releases
No news release information available for 1R01AG009216-01
History
No Historical information available for 1R01AG009216-01
Similar Projects
No Similar Projects information available for 1R01AG009216-01